These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4223122)

  • 1. Studies on progressive muscular dystrophy. I. Effects of adenosinetriphosphate and its related compounds on progressive muscular dystrophy.
    Nakahara M
    Arzneimittelforschung; 1965 Jun; 15(6):591-5. PubMed ID: 4223122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 6. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H; Schenk S
    Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical trial of creatine monohydrate in muscular dystrophy patients].
    Matsumura T; Yokoe M; Nakamori M; Hattori N; Saito T; Nozaki S; Fujimura H; Shinno S
    Rinsho Shinkeigaku; 2004 Oct; 44(10):661-6. PubMed ID: 15568480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive muscular dystrophy].
    Tsuji S; Kato F; Osawa K
    Naika; 1967 Jun; 19(6):1301-3. PubMed ID: 4865513
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy.
    Nakahara M; Yamada S
    Arzneimittelforschung; 1967 Jun; 17(6):753-6. PubMed ID: 5632380
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy].
    Radu H; Stenzel K; Blücher G; Gödri I
    Neurol Psihiatr Neurochir; 1969; 14(5):435-42. PubMed ID: 5380160
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined use of anabolic steroids and digitoxin in progressive muscular dystrophy].
    Yamamoto H; Sugita H; Furukawa T
    Iryo; 1966 Jul; 20(7):704-8. PubMed ID: 5981771
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on progressive muscular dystrophy. 1. Influence of the various drugs on serum enzyme activity and the degree of disability].
    Kanno M; Annaka S; Sato N; Shinoda M
    Iryo; 1968 Dec; 22(12):1364-71. PubMed ID: 5717702
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of electromyographic findings in subjects with progressive muscular dystrophy during remetabolizing therapy].
    Buscaino GA; Caruso G
    Riv Patol Nerv Ment; 1965 Apr; 86(2):261-7. PubMed ID: 5883603
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine].
    Radu H; Stenzel K; Migea S; Bordeianu L
    Munch Med Wochenschr; 1967 Dec; 109(51):2702-5. PubMed ID: 4873261
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the effect of corticoid administration on creatine phosphokinase in progressive muscular dystrophy].
    Barthelmai W
    Verh Dtsch Ges Inn Med; 1965; 71():624-6. PubMed ID: 5877674
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of electromyographic findings in patients with progressive muscular dystrophy during remetabolizing therapy.
    Buscaino GA; Caruso G
    Acta Neurol (Napoli); 1966; 21(1):33-45. PubMed ID: 4385733
    [No Abstract]   [Full Text] [Related]  

  • 19. ATP- and ADP-induced rat platelet aggregation: significance of plasma in ATP-induced aggregation.
    Haskel EJ; Agarwal KC; Parks RE
    Thromb Haemost; 1980 Feb; 42(5):1580-8. PubMed ID: 7368159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progressive muscular dystrophy. Results of a therapeutic trial with glucose-insulin infusions].
    Zett W; Goehler I
    Kinderarztl Prax; 1969 Jul; 37(7):312-24. PubMed ID: 5355989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.